Cyara Accelerates Growth With Senior Global Appointments
Cyara, provider of the leading Automated Customer Experience (CX) Assurance Platform, has appointed Max Lipovetsky to the role of VP Products and Russ Hellmann to VP Growth Marketing, as it accelerates its global foothold.
With over 20 years’ experience in the contact centre and IVR industry, Max Lipovetsky brings a wealth of knowledge as Cyara’s VP Products. In 2003, Max co-founded Global Speech Networks and brought to market one of the first SaaS contact centre clouds - capturing the attention of some of ANZ’s largest businesses. Based in Melbourne, Australia, Max will be instrumental in guiding Cyara through its next stage of product innovation, including the fast-evolving role of AI in testing.
Russ Hellmann, Fujitsu’s former Head of Global Demand - Digital Innovation, joins Cyara in the newly created role of VP Growth Marketing. Based in Texas, US, he will be responsible for developing a centralised capability for regional teams that will enable customer acquisition and partner activation. Russ will lead four strategic pillars of growth - Global Programmes, Digital Marketing, Field Marketing and Partner Marketing - which, together, will play an influential role in planning, building and activating campaigns that will enable Cyara to scale at speed.
These two significant additions to Cyara’s senior team follow last month’s appointments of Dean Saunders, Channel and Alliances Director of APAC, and Vikram Verma, Cyara’s first independent board member.
Max Lipovetsky, VP Products, said, “Cyara brings agility and accelerated innovation to CX, turbo-charging businesses that are driven to create the best possible experiences for their customers. Cyara does this through CX Assurance; a product category it has created almost single-handedly on a global scale. With its history of innovation and an organisational platform built for growth I’m incredibly excited to be joining Alok and the team.”
Russ Hellmann, VP Growth Marketing, said, “CX is both an art and a science - and only Cyara can measure, test and optimize for both. As the rapid and fundamental shift to the cloud continues, ensuring every facet of the CX journey is seamless has become paramount for success. With Cyara’s comprehensive assurance capabilities, expansive global partnerships and passionate people, I’m thrilled to be joining a fast-growing category leader that is pushing and redefining boundaries.”
Alok Kulkarni, CEO and Co-Founder of Cyara, added, “Securing talent like Max and Russ to help drive our product innovation, value proposition and growth strategy, places Cyara in a very unique, and fortunate position as we head into 2023. We are entering a period of massive disruption within our industry which will create risks and opportunities along the way. From our growth ambitions to our employee happiness, ensuring we have the right leaders in place is vital and I can’t wait to see the impact both Russ and Max will create for customers, partners and the team.”
About Cyara
Cyara is the world’s leading Automated Customer Experience (CX) Assurance platform, headquartered in Silicon Valley. Cyara’s cloud-based omnichannel assurance solutions for voice quality and chatbot testing accelerate the delivery of flawless customer journeys for enterprises while reducing the risk of customer-facing defects. Every day, major global brands trust the Cyara Platform to deliver customer smiles at scale. For more information, please visit cyara.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221115005525/en/
Contact information
Diana Gallagher
(408) 656-9699
10Fold Communications for Cyara
cyara@10fold.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MarkLines Gen-AI Beta Version Released for Automotive Industry13.1.2026 02:00:00 EET | Press release
MarkLines Co., Ltd. (Headquarters: Minato-ku, Tokyo; President & CEO: Makoto Sakai; TYO:3901) announced its launch of the "MarkLines Gen-AI Beta Version," the new feature for B2B users in the automotive industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112383839/en/ "MarkLines Gen-AI Beta Version" can take questions in natural language and instantly give highly reliable, relevant data drawn from MarkLines’ extensive automotive database (Image: MarkLines Co., Ltd.) This AI-powered feature enables users to ask questions in natural language and instantly receive highly reliable, relevant data drawn from MarkLines’ extensive automotive database. Moreover, the system analyzes this information by leveraging the rich content across its platform and delivers clear, concise, text-based insights. By combining trusted data with advanced analytical capabilities through generative AI, this service represents a first-of-its-kind
Australian Defence Force Secures Satellite Communications on SES IS-2212.1.2026 23:30:00 EET | Press release
Satellite communications solutions provider SES will provide secure uninterrupted satellite communications to the Australian Defence Force (ADF) for a minimum of 16 years thanks to a new extended agreement. The service will be provided via the SES Intelsat 22 satellite and an ultra-high frequency (UHF) military communications payload. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112137182/en/ Assistant Secretary Space Systems Branch, Michael Hunt, formalizes contract negotiations for the through-life support of the IS-22 satellite with Rory Welch, senior vice-president of service delivery at SES Space and Defense. Photos: Corporal Annika Smit Under the renewed arrangement, SES will reposition the IS-22 satellite to a new orbital slot specified by the ADF, continuing a mission that has been the cornerstone of Australia’s secure military communications since IS-22’s launch in 2012. SES will build a dedicated ground segmen
NetApp Appoints Paul Fipps to the Board of Directors12.1.2026 23:05:00 EET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Paul Fipps, President of Global Customer Operations at ServiceNow, has joined its Board of Directors. The board now has ten directors, nine of whom are independent, and 50% of whom have been appointed within the last five years. Fipps brings more than 20 years of experience driving technology-enabled growth and customer transformation. At ServiceNow, he currently leads global sales, customer success, partner ecosystems, and field operations. He previously served as EVP of Worldwide Sales at ServiceNow and as President of Under Armour Connected Fitness and Chief Experience Officer at Under Armour, overseeing global direct-to-consumer, connected fitness, and digital experiences. He also previously served on the advisory board of Quantum Metric. Fipps holds a B.S. in Information Systems, an MBA from the University of Baltimore, and is a graduate of The Wharton School’s Advanced Management Program. “P
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor12.1.2026 21:00:00 EET | Press release
Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study, which demonstrated deep and durable tumor responses and meaningful improvements in clinical outcomes with pimicotinib. “With pimicotinib, we have an opportunity to significantly advance care for people living with TGCT, a painful and debilitating disease that has few effective and well-tolerated treatment options beyond surgery,” said David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “Based on clinical trial results showing not only a reduction in tumor burden, but also the ability to help alleviate symptoms like pain and stiffness in the global Phase 3 MANEUVER study
Fabentech receives Marketing Authorization for Ricimed®, an antidote against ricin poisoning12.1.2026 20:32:00 EET | Press release
Fabentech, a French biopharmaceutical company specializing in medical countermeasures against biological threats, today announces that it has been granted Marketing Authorization for Ricimed®, a treatment for ricin poisoning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112241557/en/ Ricimed - Fabentech Ricimed®, an antidote against one of the most toxic natural substances in the world In addition to supportive care, and in severe situations requiring immediate administration, Ricimed® represents a new therapeutic option for the management of acute ricin intoxication. Ricin, among the most dangerous naturally occurring substances, can cause death within hours or days regardless of the route of exposure, making it a major biological threat for many countries. Having demonstrated its ability to specifically target and neutralize ricin before irreversible damage occurs, Ricimed® is an antibody-based therapy relying on poly
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom